Karrar Al-Gburi

Mr. Karrar Al-Gburi


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 September 2019 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
AAAbulfadhel Jaber Neamah Al-Shaibania
Abulfadhel Jaber Neamah Al-Shaibania
KAKarrar Al-Gburi
Karrar Al-Gburi
KHKarrar Talib Khudhair Albo Hamraha
Karrar Talib Khudhair Albo Hamraha
AAAli Mohammed Abd Alridhab
Ali Mohammed Abd Alridhab
Objective: This study was designed to prepare and characterize oil in water (o/w) nanoemulsion of candesartan cilexetil for oral administration. Preparation of candesartan cilexetil as nanoemulsion could increase its water solubility and thus could enhance its bioavailability. Methods: Aqueous titration method was used to construct the pseudo-ternary phase diagrams of nanoemulsion (NE) consisting of oil, various weight ratios of surfactant and co-surfactant (S mix), and deionized water. Different characterization techniques were conducted on the prepared nanoemulsions to obtain the optimized formula. Results: Characterizations of formula NE-4 (consists of 0.16% of candesartan cilexetil, 10% of garlic oil, 35 % of S mix (3:1) and 54.84% of deionized water) revealed the following characteristics: droplet size range (95-139 nm), polydispersity index (0.14), zeta potential value (-41.06 mV) and pH value (6.71), which are suitable for oral administration. Candesartan cilexetil in vitro release from this formula was significantly high (P<0.05) and scanning probe microscopy (SPM) study confirmed that the optimized formula (NE-4) was in nano-scale. Conclusion: Nanoemulsion formula 4 (NE-4) of candesartan cilexetil is the optimized formula and it could be a promising formula for improving the water solubility of candesartan cilaxetil.

28 February 2020 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
KHKarrar Talib Khudhair Albo Hamrah
Karrar Talib Khudhair Albo Hamrah
AAAbulfadhel Jaber Neamah Al-Shaibani
Abulfadhel Jaber Neamah Al-Shaibani
SASarmad Al-Edresi
Sarmad Al-Edresi
KAKarrar Al-Gburi
Karrar Al-Gburi
Objective: The present study was performed to compare the quality of conventional tablets loaded with candesartan cilexetil. The selected candesartan cilexetil tablets were commercialized in the Iraq market and produced by different companies. Methods: Different batches of candesartan cilexetil oral tablets (the concentration of candesartan was 8 mg) were subjected to quality control tests. Tests included weight variation, friability, hardness, drug content, disintegration time and in vitro release study. The protocols of these tests were performed according to USP pharmacopeia. Results: The results, in this study, revealed that all the used batches of candesartan cilexetil oral tablets complied with the specification of USP pharmacopeia for weight uniformity, friability value (% loss) was<1. Hardness results of the tablets were 4.9-6.6 Kg/cm2, which was within the required limits (i.e. 4-8 Kg/cm2). Disintegration time was<15 min in both Simulated Gastric Fluid (SGF) and Simulated Intestinal Fluid (SIF). The percentage of drug content in all marketed tablets was found between 96.2 % and 99.8 %, reflecting compliance with the pharmacopeia limits (i.e. 85-115 %). An in vitro release study indicated that the release of all marketed tablets exceeds 80 % within 15 min. Conclusion: All the studied tablets, loaded with candesartan cilexetil, were produced within the standard criteria of tablet production. The quality control analysis of the selected tablets, in this study, revealed satisfactory pharmaceutical properties (including safety and effectiveness) that comply within the limits of USP pharmacopeia.

18 March 2020 in Journal of Substance Use
Verified
Journal Article
Closed access
KAKarrar Al-Gburi
Karrar Al-Gburi
RARoaa Al-Murshedi
Roaa Al-Murshedi
AAAli Mohammed Abd Alridha
Ali Mohammed Abd Alridha
HBHasan Baiee
Hasan Baiee
Objective: Few data are available about drug use among Iraqi society, especially among people within the most vulnerable period, adolescence and secondary education. Hence, this study was designed to determine the prevalence and to examine the epidemiological factors associated with drug use among secondary school students. Methods: A descriptive cross-sectional school-based study was designed and students were selected using a multistage sampling method during the period from March through April 2018 in Al-Hilla city – Babil – Iraq. In the first stage, 15 secondary schools were selected using cluster sampling. Students at each secondary school, one study hall classroom per grade level were randomly selected to participate in the second stage of this study. Chi-square was used to determine if certain factors are associated significantly (pvalue ≤0.05) with drug use. Results: The overall prevalence of drug use was (9.5%) (most of them were male). Other important aspects of drug use (e.g., source of acquiring drug) among the target population were reported. A significant association between drug use and some important factors was found. Conclusion: High prevalence of drug use was shown among the students and some factors appear to play a crucial role in drug use initiation, which necessitates preventive measures.

28 April 2020 in Current Diabetes Reviews
Verified
Journal Article
Closed access
PDF file
IRIhasn Salah Rabea
Ihasn Salah Rabea
KAKarrar Al-Gburi
Karrar Al-Gburi
IAIhsan Adnan
Ihsan Adnan
BHBilal Hasan
Bilal Hasan
MMMassa Mohammed
Massa Mohammed
MMMariam Mohammed
Mariam Mohammed
Background: Nowadays, there is an accumulated data about the relation between hypomagnesemia (low Serum Mg level < 0.7 mmol/l) and diabetes. Objective: In this study, we aimed to determine the prevalence of hypomagnesemia in a carefully diagnosed diabetes patients and to show how some factors could contribute to the prevalence of low serum Mg level among the population under study. Methods: In short, 62 patients of both type 1 and 2, who attended AL-Sadir medical city/ diabetes and endocrinology centre during the period of the study were included in the study. A detailed history was taken and participants were informed verbally about the procedure of this study. Serum magnesium and creatinine were measured using standardized methods. Results: The overall prevalence of the hypomagnesemia, among diabetic population involved in this study, was 29.03 % and it was nearly similar in male (29.41 %) and female (28.57 %). The means(SD) of serum Mg level were similar in type 1 and type 2 diabetic patients. Other difference in prevalence among other characteristics has been reported. Within all participants, gender (r = -0.02), fasting blood glucose (r = -0.514) and metformin use (r = -0.014) were negatively correlated with serum Mg level, in contrast to other variables, which were positively correlated. While among type 1 DM, age (r= 0.193), serum creatinine (r= 0.031) and insulin use (r= 0.217) were positively correlated with serum Mg level. In contrast, others were negatively correlated. In type 2 DM, age (r = -0.283) and fasting blood glucose (r = -0.496) were negatively correlated with serum Mg level. On the other hand, other variables were positively correlated with serum Mg level. Conclusion: Hypomagnesemia prevalence was detected in nearly one-third of the diabetic population, which is quite high prevalence. Some factors have shown to play an essential role in this prevalence. A large study is warranted to address this issue.

7 May 2025 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
KAKarrar Al-Gburi
Karrar Al-Gburi
NNNoor H. Naser
Noor H. Naser
MJMalina Jasamai
Malina Jasamai
Objective: Emerging evidence highlights the critical role of Histone Deacetylase (HDAC) 6 in various pathologies, including cancer and neurodegenerative diseases. Therefore, we sought to computationally study new isatin-imine hybrid compounds to predict their Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) profiles and binding mode with HDAC6 through docking and molecular dynamics simulations. Methods: ADMET and drug-likeness properties of target compounds were predicted using ADMETlab 3.0. Molecular docking was conducted using Autodock4Zn embedded in Amdock v1.5.2 against HDAC6, HDAC8, and HDAC2. Utilizing Newton's equations of motion in conjunction with the Desmond package from the Schrödinger software suite, a molecular dynamics simulation of 100 nanoseconds was conducted to investigate protein-ligand interactions at the atomic level. Results: All compounds exhibited favorable physicochemical characteristics and met drug-likeness criteria, showing good absorption profile, high protein binding (except Km73 and Km74), and Human Liver Microsomal enzyme stability. Three compounds (Km66, Km68, and Km74) had low plasma clearance, while Km69, Km72, and Km73 had moderate clearance. Compounds were predicted to have favorable toxicity profiles. In docking studies on HDAC6, all compounds showed higher binding affinities (-7.44 to-10.69 Kcal/mol) than the reference compounds SAHA and Nexturastat A. For HDAC2, all compounds had a lower binding affinity than for HDAC6, except Km68, which showed a higher affinity for HDAC2 (-10.61 vs.-9.23 Kcal/mol). Km68 and Km69 demonstrated stable binding modes in molecular dynamics simulations, while Km68 showed some deviations. Conclusion: Our findings indicate that all compounds demonstrate favorable ADMET profiles, binding affinities, and selectivity towards HDAC6. Their predicted binding affinity has outperformed that of reference compounds, including SAHA and HDAC6-selective nexturastat A. This suggests that these compounds have the potential to be promising candidates for selective inhibition of HDAC6, thereby opening up new possibilities in drug development.

7 January 2022 in International Journal of Applied Pharmaceutics
Verified
Journal Article
Open access
PDF file
MAMazin Thamir Abdul-Hasan
Mazin Thamir Abdul-Hasan
AAAbulfadhel Jaber Neamah Al-Shaibani
Abulfadhel Jaber Neamah Al-Shaibani
AWAli N. Wannas
Ali N. Wannas
KAKarrar Al-Gburi
Karrar Al-Gburi
Objective: This study was employed to evaluate the quality of marketed oral tablets containing clopidogrel bisulfate. Tablets produced by various companies and commercialized in the Iraq market were used in the study. Methods: Batches of clopidogrel bisulfate conventional tablets (containing 75 mg of drug) were exposed to the quality control tests. These tests involved friability, weight variation, hardness, drug content, disintegration time, and in vitro release study; these tests were conducted depending on USP pharmacopeia. Results: The data indicate that all batches of clopidogrel bisulfate complied with the limitations of USP pharmacopeia for variation of weight, results of the hardness of tablets were 7.2-9.6 Kg/cm2. Friability value (% loss) was less than one, which was within the required limits. The time of disintegration was less than 25 min in both artificial gastric fluid (AGF) and artificial intestinal fluid (AIF). Drug content was observed between 97.1 % and 99.8 %, indicating compliance with the limits of pharmacopeia (85-115 %). An in vitro release study of batches was greater than 80 % within 25 min. Conclusion: All batches of clopidogrel bisulfate were manufactured within the criteria of tablet manufacturing. The quality control tests of tablets showed acceptable pharmaceutical properties (effectiveness and safety) that lie within the limits of USP pharmacopeia.